High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells
2016 · Journal of Clinical Investigation · 38 citations
https://doi.org/10.1172/jci86489
J
Jalila Chagraoui
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
3.3K
Citations
28
h-index
39
i10-index
Jalila Chagraoui is an academic researcher from Institute for Research in Immunology and Cancer. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Epigenetics and DNA Methylation. The author has an h-index of 28, co-authored 96 publications.
ORCID: 0000-0002-7174-0554Papers by this author
worksE4F1 Is a Master Regulator of CHK1-Mediated Functions
2015 · Cell Reports · 26 citations
https://doi.org/10.1016/j.celrep.2015.03.019
DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AML
2023 · Leukemia · 14 citations
https://doi.org/10.1038/s41375-023-02107-4
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
2025 · Biomarker Research · 4 citations
https://doi.org/10.1186/s40364-025-00769-z
DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition
2025 · EMBO Reports · 1 citations
https://doi.org/10.1038/s44319-025-00448-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat